This DUBTAC, formed by the WEE1 inhibitor AZD1775 and the OTUB1 recruiter EN523, led to a stabilization of WEE1 similar to that observed upon treatment with the proteasome inhibitor bortezomib in the hepatoma cell line HEP3B [83]. This evidence concerns the gene WEE1 and hepatocellular carcinoma.